Clinical Trials Browser

Phase 2/3 × Radiodermatitis × 90 days × Clear all

NCT07353671 2026-03-25

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Phase 2/3 Recruiting

Head and Neck Neoplasms, Radiodermatitis